Joe Rogan Seeks to Clarify His Comments on Young People and Vaccines
Podcaster Joe Rogan sought to clarify his stance on Covid-19 vaccines after suggesting young, healthy people didn’t need them. The...
health care
WSJ News Exclusive | AstraZeneca Struggles With Data Needed for Covid-19 Vaccine’s Approval
AstraZeneca AZN -1.39% PLC executives have struggled to pull together the full data necessary to apply for U.S. approval of...
U.S. to Share AstraZeneca Covid-19 Vaccine Doses With World
WASHINGTON—The Biden administration is making plans to share millions of doses of the AstraZeneca Covid-19 vaccine and preparing a major...
SPAC Insiders Can Make Millions Even When the Company They Take Public Struggles
Investors who bought into a special-purpose acquisition company that took a healthcare-services company public last year in an $11 billion...
Johnson & Johnson’s Covid-19 Shot to Be Given Again at Vaccination Sites
Health officials around the country are preparing to resume offering Johnson & Johnson’s JNJ 0.21% Covid-19 vaccine as soon as...
Pill-Dispensing Tech Makes the Medicine Go Down…With Human Help, That Is
When Stephanie Luehrs’s father began losing track of what day it was, she knew his pre-filled pill packs were no...
J&J Covid-19 Vaccine Pause Over Blood-Clot Fear Is Under Review
Johnson & Johnson’s JNJ 0.31% Covid-19 vaccine could be back in circulation this weekend—albeit with a warning or possible restrictions—depending...
WSJ News Exclusive | Pfizer Identifies Fake Covid-19 Shots Abroad as Criminals Exploit Vaccine Demand
Pfizer Inc. PFE 1.28% says it has identified in Mexico and Poland the first confirmed instances of counterfeit versions of...
EU Calls for J&J Vaccine Warning, But Says Benefits Outweigh Risks
Europe’s health agency said a warning should be added to the product information of the Johnson & Johnson Covid-19 vaccine...
Johnson & Johnson’s Covid-19 Vaccine Adds $100 Million to Quarterly Sales
Johnson & Johnson ’s Covid-19 vaccine contributed $100 million to the company’s sales growth in the latest quarter, as U.S....
Drugmakers Accused of Causing Opioid Addiction in Trial
A lawyer for several large California communities accused four drugmakers of causing a deadly wave of opioid addiction with their...
UnitedHealth Posts Stronger Quarterly Results as Membership Grows
UnitedHealth UNH 3.83% Group Inc. recorded a first-quarter profit that beat Wall Street’s expectations and raised its projection on results...
U.S. Vaccine Panel Delays Vote on J&J Covid-19 Shot’s Blood-Clotting Risk
The federal government’s recommendation to pause using Johnson & Johnson’s Covid-19 vaccine will remain in place after an advisory panel...
U.S. Seeks to Pause J&J Covid-19 Vaccine Use After Rare Blood-Clot Cases
U.S. health authorities recommended a pause in the use of Johnson & Johnson’s Covid-19 vaccine in order to investigate rare...
Covid-19 Drug Prevents Symptomatic Disease in Study, Regeneron Says
An antibody drug from Regeneron Pharmaceuticals Inc. reduced the risk of developing symptomatic Covid-19 infection by 81% compared with a...
Biden Tests Tech Giants’ Support for Global Tax Reform
For the world’s largest companies, global tax policy is proving the adage that you should be careful what you wish...
U.K. Limits AstraZeneca Covid-19 Vaccine to Over-30s Amid Blood-Clot Concerns
The U.K.’s vaccines advisory body said the Covid-19 vaccine produced by AstraZeneca PLC should preferably not be given to people...
Facebook, Apple and Niantic Bet People Are Ready for Augmented-Reality Glasses
Tech companies are accelerating their development of computerized glasses for consumers, in a competition between Facebook Inc., Apple Inc. and...
Airlines Want Vaccine Passports but Don’t Want to Pay for Them
LONDON—Airlines are resisting early European Union plans that could push some of the costs and responsibility for implementing vaccination passports...
FTC Seeks to Block Illumina’s $7.1 Billion Acquisition of Life Sciences Firm Grail
WASHINGTON—The Federal Trade Commission filed suit Tuesday to block Illumina Inc.’s planned $7.1 billion acquisition of a company developing an...
